OBJECTIVE: Depression is a risk factor for cardiac events in patients with coronary heart disease (CHD). Obstructive sleep apnea/hypopnea syndrome (OSAHS) is frequently comorbid with depression and is also a risk factor for cardiac events. Undetected OSAHS could help explain the increased risk associated with depression. METHODS: Medically stable patients with CHD and major (MD, n = 53), minor (md, n = 36), or no depression (ND, n = 43) were evaluated for 2 nights in a sleep medicine laboratory. RESULTS: The prevalence of OSAHS did not differ across groups (MD 66%, md 69%, ND 77%; p > .05). Patients with MD had a significantly greater frequency of apneic episodes, a significantly longer duration of apneas and hyponeas, and more oxygen desaturations per hour than those with md, but there were no differences between MD and ND in frequency of apneic episodes or oxygen desaturations. However, males with MD tended to have more obstructive episodes per hour than did ND males, whereas females with MD had fewer episodes than did ND females. Apnea duration was longer in patients with MD compared with patients with no ND. There was no difference in the mean duration of apnea per hour between the md and ND groups. CONCLUSIONS: Although OSAHS is not more common in depressed patients with CHD, MD is associated with longer obstructive sleep apneic episodes in both men and women and with a higher frequency of episodes in men.
OBJECTIVE:Depression is a risk factor for cardiac events in patients with coronary heart disease (CHD). Obstructive sleep apnea/hypopnea syndrome (OSAHS) is frequently comorbid with depression and is also a risk factor for cardiac events. Undetected OSAHS could help explain the increased risk associated with depression. METHODS: Medically stable patients with CHD and major (MD, n = 53), minor (md, n = 36), or no depression (ND, n = 43) were evaluated for 2 nights in a sleep medicine laboratory. RESULTS: The prevalence of OSAHS did not differ across groups (MD 66%, md 69%, ND 77%; p > .05). Patients with MD had a significantly greater frequency of apneic episodes, a significantly longer duration of apneas and hyponeas, and more oxygen desaturations per hour than those with md, but there were no differences between MD and ND in frequency of apneic episodes or oxygen desaturations. However, males with MD tended to have more obstructive episodes per hour than did ND males, whereas females with MD had fewer episodes than did ND females. Apnea duration was longer in patients with MD compared with patients with no ND. There was no difference in the mean duration of apnea per hour between the md and ND groups. CONCLUSIONS: Although OSAHS is not more common in depressedpatients with CHD, MD is associated with longer obstructive sleep apneic episodes in both men and women and with a higher frequency of episodes in men.
Authors: Kenneth E Freedland; Robert M Carney; Junichiro Hayano; Brian C Steinmeyer; Rebecca L Reese; Annelieke M Roest Journal: J Psychosom Res Date: 2012-01-28 Impact factor: 3.006
Authors: Junichiro Hayano; Robert M Carney; Eiichi Watanabe; Kiyohiro Kawai; Itsuo Kodama; Phyllis K Stein; Lana L Watkins; Kenneth E Freedland; James A Blumenthal Journal: Psychosom Med Date: 2012-09-28 Impact factor: 4.312
Authors: Christine Norra; Julia Kummer; Maren Boecker; Erik Skobel; Patrick Schauerte; Markus Wirtz; Siegfried Gauggel; Thomas Forkmann Journal: Int J Behav Med Date: 2012-12
Authors: Annelieke M Roest; Robert M Carney; Phyllis K Stein; Kenneth E Freedland; Hilary Meyer; Brian C Steinmeyer; Peter de Jonge; Eugene H Rubin Journal: J Clin Psychiatry Date: 2011-08-09 Impact factor: 4.384
Authors: Robert M Carney; Kenneth E Freedland; Phyllis K Stein; Gregory E Miller; Brian Steinmeyer; Michael W Rich; Stephen P Duntley Journal: J Psychosom Res Date: 2007-04 Impact factor: 3.006
Authors: Robert M Carney; Brian Steinmeyer; Kenneth E Freedland; James A Blumenthal; Phyllis K Stein; William A Steinhoff; William B Howells; Lisa F Berkman; Lana L Watkins; Susan M Czajkowski; Peter P Domitrovich; Matthew M Burg; Junichiro Hayano; Allan S Jaffe Journal: Psychosom Med Date: 2008-08-25 Impact factor: 4.312